Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miryam Horovitz-Fried
Human T Cells Engineered to Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity
Journal of Immunology
Allergy
Immunology
The Mutational Status of P53 Can Influence Its Recognition by Human T-Cells
OncoImmunology
Oncology
Allergy
Immunology
Related publications
miR-28 Modulates Exhaustive Differentiation of T Cells Through Silencing Programmed Cell Death-1 and Regulating Cytokine Secretion
Oncotarget
Oncology
Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Mechanisms for Enhanced Antitumor Immune Responses Induced by Irradiated Hepatocellular Carcinoma Cells Engineered to Express Hepatitis�B Virus X Protein
Oncology Letters
Cancer Research
Oncology
Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma
Archives of Dermatology
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Journal of Immunology
Allergy
Immunology
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Programmed Death-1 Impairs Secondary Effector Lung CD8+T Cells During Respiratory Virus Reinfection
Journal of Immunology
Allergy
Immunology
Engineered T Cells Bypass Death Signaling and Bolster Immunotherapy
Cancer Discovery
Oncology
Enhanced Antitumor Activity of Cerulenin Combined With Oxaliplatin in Human Colon Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
